Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2013

View Archived Issues

Kinexus updates on PhosphoNET KnowledgeBase

New immunohistochemistry kit for diagnosis and prognosis of invasive tumors

New means of converting stem cells to naive state discovered at Minerva Biotechnologies

Stanford University presents new PKC-delta inhibitors

Scientists at the University of Utah present novel LSD1 inhibitors for cancer

Diaxonhit presents new DYRK1A/1B inhibitors

Vasomera demonstrates improvement in left ventricular function in vivo

Preclinical results for intranasal gemcitabine

Danegaptide hydrochloride shown to reduce infarct size in vivo

Tenecteplase significantly affects primary outcome measure in PEITHO trial

Tragara Pharmaceuticals presents pharmacokinetic data for TG-02 citrate

Boehringer Ingelheim presents new agents for viral infections

Merck KGaA divulges new FAK inhibitors

Takeda Pharmaceutical synthesizes new DAAO inhibitors

Gedeon Richter and Orion Corporation to collaborate on cognitive disorders

Biogen Idec submits BLA for factor VIII therapy

Chimerix's CMX-001 obtains FDA fast track status for cytomegalovirus infections

Vifor Pharma reports new regulatory submission for PA-21 in Switzerland

Shire acquires biotechnology company

Lithera begins phase IIb trial of LIPO-202 for the reduction of subcutaneous fat

Detailed results from CHAMPION PHOENIX cangrelor trial presented

Presidio and Boehringer Ingelheim to collaborate on study of combination treatment for HCV infection

Armetheon to develop tecarfarin as alternative to warfarin

Qurient gains exclusive worldwide rights to new kinase inhibitor for metastatic cancer

FDA approves IND for phase I/II trial of ACT's hESC-derived cells to treat severe myopia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...